Skip to main content
. 2023 Oct 24;2023(10):CD014967. doi: 10.1002/14651858.CD014967.pub2

NCT04320940.

Study name Efficacy and safety of intravenous phenobarbital in neonatal seizures
Methods RCT, double‐blind
Participants Neonates > 33 weeks with high probability of seizures, cEEG, seizures for at least 30 s/h
Interventions PB 20/kg (if required plus 20) vs PB 40 mg/kg (if required plus 10)
Outcomes No requirement of ASM after 1st dose PB at 24 hours; no requirement of ASM after 1st dose PB at 2 hours; no requirement of ASM after 2nd dose of PB; seizure burden
Starting date 2020
Contact information rnoor@nemaresearch.net
Notes Calculated sample size 490; very interesting study